Active, Not Recruiting Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors NCT05215574 Conditions Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more Locations NGM Clinical Study Site — Gilbert, Arizona, United States NGM Clinical Study Site — Los Angeles, California, United States NGM Clinical Study Site — Sarasota, Florida, United States NGM Clinical Study Site — Tampa, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details